A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNAMaria Cristina Pirosa, Luca Ceriani, Ilaria Romano et al.|Blood|2025Cited by 19
S225: CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER AT BASELINE AND IMPROVES THE ACCURACY OF INTERIM PET IN CLASSIC HODGKIN LYMPHOMAMaria Cristina Pirosa, Davide Rossi, Alessio Bruscaggin et al.|HemaSphere|2022Cited by 1
Non-Coding Mutations of <i>BCL6</i> in Classical Hodgkin LymphomaMaria Cristina Pirosa, Davide Rossi, Matin Salehi et al.|Blood|2024Cited by 1
A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using CtdnaMatin Salehi, Davide Rossi, Maria Cristina Pirosa et al.|Blood|2024Cited by 1
Clinical utility of circulating tumor DNA qualification and quantification in classical Hodgkin lymphomaMaria Cristina Pirosa, Davide Rossi, Alessio Bruscaggin et al.|Hematological Oncology|2023Cited by 0